Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
Date:2/6/2008

SEATTLE, Feb. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) management will present at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12th at 1:15 PM in the West Foyer of the Waldorf-Astoria Hotel.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at http://www.cticseattle.com.

BIO CEO & Investor Conference

CTI Presentation: Tuesday, February 12, 2008

1:15 PM EST/7:15 PM CET/10:15 AM PST

West Foyer, Waldorf-Astoria Hotel

Audio webcast with slides at http://www.cticseattle.com

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Leah Grant

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 F: 206.272.4434

Susan Callahan E: invest@ctiseattle.com

T: 206.272.4472

F: 206.272.4434

E: media@ctiseattle.com

http://www.cticseattle.com/media.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
2. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
3. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
4. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
5. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
8. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
9. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
10. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...he New York investment bank KTA Capital,s client N...AU$6.7 mil convertible note private placement with...ent was arranged by KTA Capital as Neuren,s exclus... New York (PRWEB) November 23, 2009 -- Th..., LLC ("KTA Capital") has announced that...
(Date:11/24/2009)...ov. 24 Sigma-Aldrich Cor...e NASDAQ OMX conference on Tuesday, December 1st a...d parties may listen via live audio broadcast over...ig m a a ldrich.com/ . Users can click the "... Sigma-Aldrich: Sigma-Aldrich is a leading Life ...
(Date:11/24/2009)...Calif., Nov. 24 Neuroges...any focused on developing and commercializing nove...Anthony DiTonno, President and Chief Executive Off...iper Jaffray Health Care Conference, to be held De...ew York, New York. ,, Mr. DiTonno and Stephen ...
(Date:11/24/2009)...fficacy endpoint has been met for patients with ad..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced positive efficacy data from a Phase 2...te, AEZS-108 (formerly AN-152), in patients with a...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...stics,Inc. (OTC Bulletin Board: BOVD) ("Boveran") ...t ("LOI") to acquire majority interest in Sophora,...ology lab ("Sophora")., Pursuant to the LOI, Dr. ...he Company,s Chief Pathologist and Director of Lab... lab services., Sophora is Boveran,s first planne...
...are Simplifies Medicare - For Free, MAYNARD, Mass...atest release of their PlanPrescriber tool. Medica... worry about whether they are,getting the most out...er,the brainchild of MIT Professor Glen Urban, pro...seniors quickly find their best Medicare insurance...
...erations, NAPLES, Fla., Sept. 8 Algenol Biofuels...vanced third generation biofuels,technology, today...as Chief,Science Officer. Dr. Coleman, currently t... the University of Toronto, has over 20 years of,e...iochemistry of,photosynthetic carbon metabolism in...
Other Biology Technology:Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc. 2On-Line Medicare Advisor Saves Seniors Time, Hassle and Money 2Algenol Biofuels Appoints Chief Science Officer 2
(Date:11/25/2009)...the California Institute of Technology (Caltech) h... behavior in the fruit fly, Drosophila melanogast...the relationship between the neurotransmitter dopa...(ADHD), are described in the December issue of the...ains only about 20,000 neurons and has long been c...
(Date:11/25/2009)...ve easy lives. In addition to mammalian immune sys...ies called bacteriophages, viruses that kill half ...bacteria and another class of microorganisms calle...s such as deep-sea volcanic vents) manage just fin... defense system that helps protect them from many ...
(Date:11/25/2009)...he Cell Death Research Laboratory in the Universit...ed the prestigious Johnson & Johnson Focused Fundi...rain cell damage in Parkinson,s disease. The award...ort of innovation and excellence in science, was a... this month at an event at the Hyatt Regency Hotel...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2American Oriental Bioengineering Announces Change in Independent Auditor 13494 1For Macho Men Doctor Visits Are Less Likely 54168 1For Macho Men Doctor Visits Are Less Likely 54168 2Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 1Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 2Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 3Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 4Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 5Vion Pharmaceuticals Reports 2009 Second Quarter And Six Month Results 54163 6
...is release is also available in French . , Mon...ied what may be a pivotal first step towards the r...njury, using the bodys own stem cells. , This s...of the National Academy of Science, identifies key...critical information that could lead to novel ther...
...entists at John Carroll University, working in its... affordable accessory that appears to reduce the s...n shown to improve sleep patterns among people who... researchers have created glasses designed to bloc...an rhythm, which leads to improvement in ADHD symp...
...kville, Md., November 12, 2007 On September 10, 2...t several multivitamin supplements did not contain...s, B-50 Tablets, manufactured by IVC, Industries, ... Supplement Verification Program and carries the U...tudied the verified product to confirm the announc...
Other Biology News:Researchers take first steps towards spinal cord reconstruction following injury 2Market testing of dietary supplements and drugs underscores value of USP's public health programs 2
GeneAmp PCR System 2700 from Applied Biosystems
...low Perm/Wash Buffer I can be used in intracellula...ing proteins to permeabilize cells and to serve as... saponin-mediated cell permeabilization is a rever...n the presence of saponin during intracellular sta...
Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation
...endly Eppendorf Thermomixer R offers maximum appli...quire shaking, heating, and cooling. Its active he...plication and temperature control ranges. Five dif... micro test tubes, are available for: 0.5 ml, 1.5 ...
Biology Products: